IN SITU GEL POLYMERS: A REVIEW
In situ gels have become one of the most prominent and accessible systems. These systems have several advantages like simple manufacturing, easy to use, improved adherence, and patient comfort by minimizing drug administration frequency by its unique characteristic features of sol to gel transition. In the 'sol-gel' method, the precursor goes through hydrolysis and polymerization or condensation to produce a colloidal suspension or solution. As they can administer in solution form, these in situ gelling systems undergo gelation at the achievement site. Some researchers recently developed in situ gelling systems of liposomes, microspheres, nanoemulsions, nanospheres, etc. This review mainly focused on the introduction, advantages, disadvantages, types of polymers, and suitable characteristics for preparing in situ gels.
2. Sarada K, Firoz S, Padmini K. In-situ gelling system: a review. Int J Curr Pharm Rev Res 2014;5:76-90.
3. Song Y, Wang Y, Thakur R, Meidan VM, Michniak B. Mucosal drug delivery: membranes, methodologies, and applications. Crit Rev Ther Drug Carrier Syst 2004;21:89-100.
4. P Venkatesh M, K Liladhar P, MP Kumar T, G Shivakumar H. In situ gels based drug delivery system. Curr Drug Ther 2011;6:213-22.
5. Das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm 2006;318:1-4.
6. Pasparakis G, Vamvakaki M. Multiresponsive polymers: nano-sized assemblies, stimuli-sensitive gels and smart surfaces. Polym Chem 2011;2:1234-48.
7. Figueira RB, Silva CJ, Pereira EV. Organic–inorganic hybrid sol–gel coatings for metal corrosion protection: a review of recent progress. J Coat Technol Res 2015;12:1-35.
8. Bae Y, Kataoka K. Intelligent polymeric micelles from functional poly (ethylene glycol)-poly (amino acid) block copolymers. Adv Drug Delivery Rev 2009;61:768-84.
9. Mano JF. Stimuli?responsive polymeric systems for biomedical applications. Adv Eng Mater 2008;10:515-27.
10. Prasanthi S, Vidhyavathi M. Formulation and optimization of buoyant in situ gelling system of valsartan using natural polymer. Int J Pharm Pharm Sci 2017;10:128-36.
11. Maharjan R, Subedi G. Formulation and evaluation of floating in-situ gel of ranitidine using natural polymers. Int J Pharm Pharm Sci 2014;6:205-9.
12. Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics. Drug Delivery 2016;23:2371-90.
13. Phad AR, Dilip NT, Ganapathy RS. Emulgel: a comprehensive review for topical delivery of hydrophobic drugs. Asian J Pharm 2018;12:S382-93.
14. HB N, Bakliwal SR, Pawar SP. In-situ gel: new trends in controlled and sustained drug delivery system. Int J Pharmtech Res 2010;2:1398-408.
15. Kaur P, Garg T, Rath G, Goyal AK. In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane. Artif Cells Nanomed Biotechnol 2016;44:1167-76.
16. Hsiue GH, Chang RW, Wang CH, Lee SH. Development of in situ thermosensitive drug vehicles for glaucoma therapy. Biomaterials 2003;24:2423-30.
17. Madan M, Bajaj A, Lewis S, Udupa N, Baig JA. In situ forming polymeric drug delivery systems. Indian J Pharm Sci 2009;71:242-51.
18. Kute JU, Darekar AB, Saudagar RB. A review: an in-situ gel-novel approach for nasal delivery. World J Pharm Pharm Sci 2013;3:187-203.
19. Fakhari A, Subramony JA. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. J Controlled Release 2015;220:465-75.
20. Liu Y, Wang X, Liu Y, Di X. Thermosensitive in situ gel based on solid dispersion for rectal delivery of ibuprofen. AAPS PharmSciTech 2018;19:338-47.
21. Harish NM, Prabhu P, Charyulu RN, Gulzar MA, Subrahmanyam EV. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis. Indian J Pharm Sci 2009;71:421-7.
22. Sonowal B, Deb P, Dash S. Studies on in-situ forming thermosensitive injectable polymeric gel for sustained drug delivery. Res J Pharm Technol 2017;10:1840-7.
23. Prasannan A, Tsai HC, Chen YS, Hsiue GH. A thermally triggered in situ hydrogel from poly (acrylic acid-co-N-isopropylacrylamide) for controlled release of anti-glaucoma drugs. J Mater Chem B 2014;2:1988-97.
24. Khan S, Patil K, Bobade N, Yeole P, Gaikwad R. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target 2010;18:223-34.
25. Jeong B, Kim SW, Bae YH. Thermosensitive sol–gel reversible hydrogels. Adv Drug Delivery Rev 2012;64:154-62.
26. Matyjaszewski K, Tsarevsky NV. Nanostructured functional materials prepared by atom transfer radical polymerization. Nature Chem 2009;1:276-88.
27. Gupta H, Velpandian T, Jain S. Ion-and pH-activated novel in-situ gel system for sustained ocular drug delivery. J Drug Target 2010;18:499-505.
28. Bai B, Zhou J, Yin M. A comprehensive review of polyacrylamide polymer gels for conformance control. Pet Explor Dev 2015;42:525-32.
29. Xin C, Lihong W, Qiuyuan L, Hongzhuo L. Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluation. Int J Pharm 2014;469:23-30.
30. Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004;58:445-55.
31. Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Controlled Release 2002;80:9-28.
32. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Delivery Rev 2009;61:158-71.
33. Rees CA, Provis JL, Lukey GC, Van Deventer JS. In situ ATR-FTIR study of the early stages of fly ash geopolymer gel formation. Langmuir 2007;23:9076-82.
34. Gong C, Shi S, Wu L, Gou M, Yin Q, Guo Q, et al. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL–PEG–PCL hydrogel. Part 2: sol-gel–sol transition and drug delivery behavior. Acta Biomater 2009;5:3358-70.
35. Shinde UP, Yeon B, Jeong B. Recent progress of in situ formed gels for biomedical applications. Progress in polymer science. Prog Polym Sci 2013;38:672-701.
36. Mundada AS, Avari JG. In situ gelling polymers in ocular drug delivery systems: a review. Crit Rev Ther Drug Carrier Syst 2009;26:85-118.
37. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
38. Patil S, Kadam A, Bandgar S, Patil S. Formulation and evaluation of an in situ gel for ocular drug delivery of anticonjunctival drug. Cellul Chem Technol 2015;49:35-40.
39. Saini R, Saini S, Singh G, Banerjee A, Railmajra DS. In situ gels-a new trends in ophthalmic drug delivery systems. Int J Pharm Sci Res 2015;6:386-90.
40. Mahajan HS, Tyagi VK, Patil RR, Dusunge SB. Thiolated xyloglucan: synthesis, characterization and evaluation as mucoadhesive in situ gelling agent. Carbohydr Polym 2013;91:618-25.
41. Gupta S, Samanta MK, Raichur AM. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPS PharmSciTech 2010; 11:322-35.
42. Chang CF, Wang SC, Shigeto S. In situ ultra low-frequency raman tracking of the polymorphic transformation of crystalline 1, 1?-binaphthyl. J Phys Chem C 2014;118:2702-9.
43. Bashir A, Manzoor T, Malik LA, Qureashi A, Pandith AH. Enhanced and selective adsorption of Zn (II), Pb (II), Cd (II), and Hg (II) Ions by a dumbbell-and flower-shaped potato starch phosphate polymer: a combined experimental and DFT calculation study. ACS Omega 2020;5:4853-67.
44. Raizada A, Bandari A, Kumar B. Polymers in drug delivery: a review. Int J Pharm Pharm Res Dev 2010;2:9-20.
45. Boateng J, Okeke O, Khan S. Polysaccharide based formulations for mucosal drug delivery: a review. Curr Pharm Des 2015;21:4798-821.
46. Tinu TS, Litha T, Kumar Anil B. Polymers used in ophthalmic in situ gelling system. Int J Pharm Sci Rev Res 2013;20:176-83.
47. Mohanty D, Bakshi V, Simharaju N, Haque MA, Sahoo CK. A review on in-situ gel: a novel drug delivery system. Int J Pharm Sci Rev Res 2018;50:175-811.
48. Reddy K, Krishna Mohan G, Satla S, Gaikwad S. Natural polysaccharides: versatile excipients for controlled drug delivery systems. Asian J Pharma Sci 2011;6:275-86.
49. Li L, Ni R, Shao Y, Mao S. Carrageenan and its applications in drug delivery. Carbohydr Polym 2014;103:1-11.
50. MacArtain P, Jacquier JC, Dawson KA. Physical characteristics of calcium-induced ?-carrageenan networks. Carbohydr Polym 2003;53:395-400.
51. Honarkar H, Barikani M. Applications of biopolymers I: chitosan. Monatshefte Chemie Chem 2009;140:1403-20.
52. Mourya VK, Inamdar NN. Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med 2009;20:1057-79.
53. Seuring J, Agarwal S. Polymers with upper critical solution temperature in aqueous solution. Macromol Rapid Commun 2012;33:1898-920.
54. Usman A, Zia KM, Zuber M, Tabasum S, Rehman S, Zia F. Chitin and chitosan-based polyurethanes: a review of recent advances and prospective biomedical applications. Int J Biol Macromol 2016;86:630-45.
55. Ali A, Ahmed S. A review on chitosan and its nanocomposites in drug delivery. Int J Biol Macromol 2018;109:273-86.
56. Guad RS, Surana SJ, Talele GS, Talele MS, Gokhale MS. Natural excipients. Pragati Books Pvt. Ltd.; 2006.
57. Smelcerovic A, Knezevic Jugovic Z, Petronijevic Z. Microbial polysaccharides and their derivatives as current and prospective pharmaceuticals. Curr Pharm Des 2008;14:3168-95.
58. Izydorczyk M, Cui SW, Wang Q. Polysaccharide gums: structures, functional properties, and applications. Food Carbohydr: Chem Physical Propert Applic; 2005. p. 293-9.
59. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Controlled Release 2007;119:5-24.
60. Gawkowska D, Cybulska J, Zdunek A. Structure-related gelling of pectins and linking with other natural compounds: a review. Polym 2018;10:762.
61. Synytsya A, Copikova J, Matejka P, Machovic V. Fourier transform Raman and infrared spectroscopy of pectins. Carbohydr Polym 2003;54:97-106.
62. Sharma BR, Naresh L, Dhuldhoya NC, Merchant SU, Merchant UC. An overview on pectins. Times Food Process J 2006;23:44-51.
63. Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomaterialia 2013;9:7081-92.
64. Schiraldi C, La Gatta A, De Rosa M. Biotechnological production and application of hyaluronan. Biopolymers 2010;20:387-412.
65. Fallacara A, Manfredini S, Durini E, Vertuani S. Hyaluronic acid fillers in soft tissue regeneration. Facial Plast Surg 2017;33:87-96.
66. Majee SB, Avlani D, Biswas GR. Non-starch plant polysaccharides: physicochemical modifications and pharmaceutical applications. J Appl Pharm Sci 2016;6:231-41.
67. Kapoor M, Khandal RK, Seshadri G, Aggarwal S, Kumar Khandal R. Novel hydrocolloids: preparation and applications–a review. Int J Recent Res Appl Stud 2013;16:432-82.
68. Kulkarni AD, Joshi AA, Patil CL, Amale PD, Patel HM, Surana SJ, et al. Xyloglucan: a functional biomacromolecule for drug delivery applications. Int J Biol Macromol 2017;104:799-812.
69. Grabovac V, Guggi D, Bernkop Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Delivery Rev 2005;57:1713-23.
70. Sun X, Zhang N. Cationic polymer optimization for efficient gene delivery. Mini Rev Med Chem 2010;10:108-25.
71. Sreenivas SA, Pai KV. Thiolated chitosans: novel polymers for mucoadhesive drug delivery–a review. Trop J Pharm Res 2008;7:1077-88.
72. Bernkop Schnürch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm 2004;57:9-17.
73. Mokhtarzadeh A, Alibakhshi A, Hejazi M, Omidi Y, Dolatabadi JE. Bacterial-derived biopolymers: advanced natural nanomaterials for drug delivery and tissue engineering. Trends Anal Chem 2016;82:367-84.
74. Rinaudo M. Main properties and current applications of some polysaccharides as biomaterials. Polym Int 2008;57:397-430.
75. Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013; 39:1599-617.
76. Ruel Gariepy E, Leroux JC. In situ-forming hydrogels review of temperature-sensitive systems. Eur J Pharm Biopharm 2004;58:409-26.
77. Almeida H, Amaral MH, Lobao P, Lobo JM. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discovery Today 2014;19:400-12.
78. Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Delivery Rev 2010;62:83-99.
79. Chang C, Zhang L. Cellulose-based hydrogels: present status and application prospects. Carbohydr Polym 2011;84:40-53.
80. Gambhire SA, Bhalerao KA, Singh S. In situ hydrogel: different approaches to ocular drug delivery. Int J Pharm Pharm Sci 2013;5:27-36.
81. Xu Y, Wang C, Tam KC, Li L. Salt-assisted and salt-suppressed sol-gel transitions of methylcellulose in water. Langmuir 2004;20:646-52.
82. Rajoria G, Gupta A. In-situ gelling system: a novel approach for ocular drug delivery. Am J PharmTech Res 2012;2:24-53.
83. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 2002;28:353-69.
84. Wagh VD, Inamdar B, Samanta MK. Polymers used in ocular dosage form and drug delivery systems. Asian J Pharm 2008;2:12-7.
85. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as a biodegradable controlled drug delivery carrier. Polym 2011;3:1377-97.
86. Hines DJ, Kaplan DL. Poly (lactic-co-glycolic) acid? controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst 2013;30:257-76.
87. Tyler B, Gullotti D, Mangraviti A, Utsuki T, Brem H. Polylactic acid (PLA) controlled delivery carriers for biomedical applications. Adv Drug Delivery Rev 2016;107:163-75.
88. Maheswaran A, Padmavathy J, Nandhini V, Saravanan D, Angel P. Formulation and evaluation of floating oral in situ gel of diltiazem hydrochloride. Int J Appl Pharm 2017;9:50-3.
89. Dhir S, Ali Saffi K, Kamalpuria N, Mishra D. An overview of in situ gelling systems. Inter J Pharma Life Sci 2016;7:5135-56.
90. Gu D, O'Connor AJ, GH Qiao G, Ladewig K. Hydrogels with smart systems for delivery of hydrophobic drugs. Expert Opin Drug Delivery 2017;14:879-95.
91. Gonzalez Lopez J, Alvarez Lorenzo C, Taboada P, Sosnik A, Sandez Macho I, Concheiro A. Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers. Langmuir 2008;24:10688-97.
92. Alvarez Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets 2011;12:1112-30.
93. Almeida M, Magalhães M, Veiga F, Figueiras A. Poloxamers, poloxamines and polymeric micelles: definition, structure and therapeutic applications in cancer. J Polym Res 2018;25:31.
94. Gonzalez Gaitano G, Ramon Isasi J, Velaz I, Zornoza A. Drug carrier systems based on cyclodextrin supramolecular assemblies and polymers: present and perspectives. Curr Pharm Des 2017;23:411-32.
95. Vicario-de-la-Torre M, Forcada J. The potential of stimuli-responsive nanogels in drug and active molecule delivery for targeted therapy. Gels 2017;3:16.
96. Chen SY, Hu SH, Liu TY. Magnetic-responsive nanoparticles for drug delivery. Smart Materials Drug Delivery 2013:2:32-62.
97. Dhara D, Rathna GV, Chatterji PR. Volume phase transition in interpenetrating networks of poly (N-isopropylacrylamide) with gelatin. Langmuir 2000;16:2424-9.
98. Xie D, Ye X, Ding Y, Zhang G, Zhao N, Wu K, et al. Multistep thermosensitivity of poly (N-n-propylacrylamide)-block-poly (N-isopropylacrylamide)-block-poly (N, N-ethylmethyl-acrylamide) triblock terpolymers in aqueous solutions as studied by static and dynamic light scattering. Macromolecules 2009;42:2715-20.
This work is licensed under a Creative Commons Attribution 4.0 International License.